Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00284206
Status:
COMPLETED
Last Update Posted:
2008-01-11
First Post:
2006-01-27
Brief Title:
A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
Sponsor:
Seattle Institute for Biomedical and Clinical Research
Organization:
Seattle Institute for Biomedical and Clinical Research
Organization Data
Organization:
Seattle Institute for Biomedical and Clinical Research
Class:
OTHER
Study ID:
RIS-NAP-4008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen LP | INDUSTRY |